Cargando…

COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options

The 2019 novel coronavirus (COVID-19) has quickly become one of the most dire international pandemic crises since the 1918 Spanish flu. Evidence for COVID-19 pharmacological therapies has shown rapid growth and a diverse array of results, but an assessment of the value of each piece of evidence must...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebold, Nicholas, Holger, Dana, Alosaimy, Sara, Morrisette, Taylor, Rybak, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831619/ https://www.ncbi.nlm.nih.gov/pubmed/33495967 http://dx.doi.org/10.1007/s40121-021-00399-6

Ejemplares similares

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
por: Holger, Dana J., et al.
Publicado: (2022)

Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19
por: Rebold, Nicholas, et al.
Publicado: (2022)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections
por: Rebold, Nicholas, et al.
Publicado: (2021)

Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH Study
por: Alosaimy, Sara, et al.
Publicado: (2021)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
por: Rebold, Nicholas, et al.
Publicado: (2023)

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
por: Morrisette, Taylor, et al.
Publicado: (2020)

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Holger, Dana, et al.
Publicado: (2021)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2022)

Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
por: Alosaimy, Sara, et al.
Publicado: (2020)

132. Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems
por: Holger, Dana, et al.
Publicado: (2021)

Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens
por: Morrisette, Taylor, et al.
Publicado: (2022)

A Narrative Review of Existing Options for COVID-19-Specific Treatments
por: Yadullahi Mir, Wasey Ali, et al.
Publicado: (2021)

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
por: Kunz Coyne, Ashlan J, et al.
Publicado: (2023)

1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections
por: Ghali, Amer El, et al.
Publicado: (2022)

1290. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial and Gram-Negative Infections: A Multicenter Evaluation
por: Morrisette, Taylor, et al.
Publicado: (2020)

Current and emerging evidence-based treatment options in chronic migraine: a narrative review
por: Agostoni, Elio Clemente, et al.
Publicado: (2019)

The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data
por: Tang, Wei, et al.
Publicado: (2021)

Older persons’ narrations on falls and falling—Stories of courage and endurance
por: Clancy, Anne, et al.
Publicado: (2015)

Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review
por: Kwon, Seungwon, et al.
Publicado: (2020)

Essay Read before the Late Dental Convention at Niagara Falls
por: Taylor, Jas.
Publicado: (1859)

Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination
por: Kebriaei, Razieh, et al.
Publicado: (2022)

Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium
por: Lev, Katherine, et al.
Publicado: (2022)

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
por: Morrisette, Taylor, et al.
Publicado: (2021)

A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)
por: Mirzaie, Amir, et al.
Publicado: (2020)

Surgical Protocols before and after COVID-19—A Narrative Review
por: Shivkumar, Sahana, et al.
Publicado: (2023)

1573. Daptomycin Resistant Enterococcus faecium: Combination Therapy Screening
por: Kebriaei, Razieh, et al.
Publicado: (2020)

A Narrative Review of New Treatment Options for Diabetic Nephropathy
por: Pillai, Aadhira, et al.
Publicado: (2023)

Catch those antibodies before they fall
por: Shaz, Beth H., et al.
Publicado: (2020)

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
por: Barber, Katie E., et al.
Publicado: (2021)

Unlocking the black box: Non-parametric option pricing before and during COVID-19
por: Gradojevic, Nikola, et al.
Publicado: (2022)

COVID-19: Immunology and treatment options
por: Felsenstein, Susanna, et al.
Publicado: (2020)

Medical treatment options for COVID-19
por: Delang, Leen, et al.
Publicado: (2020)

Before narrative: episodic reading and representations of chronic pain
por: Wasson, Sara
Publicado: (2018)

Treatment options for massive rotator cuff tears: a narrative review
por: Mancuso, Francesco, et al.
Publicado: (2021)

Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022)

Epilepsy and COVID-19: Updated evidence and narrative review
por: Kuroda, Naoto
Publicado: (2021)

High-flow nasal oxygen in acute hypoxemic respiratory failure: A narrative review of the evidence before and after the COVID-19 pandemic
por: Genecand, Léon, et al.
Publicado: (2022)

Treatment Options for Acute Agitation in Psychiatric Patients: Theoretical and Empirical Evidence
por: Zareifopoulos, Nicholas, et al.
Publicado: (2019)

Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review
por: Safari, Saeid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mikq7ol1rlb4bj9g90itkdp8vb